Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT07089264
Active, not recruiting Not applicable

Physical Rehabilitation in Patients With Complex Congenital Heart Disease

NCT07089264 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2019-09-01
Last updated
2025-07-28

Condition(s) studied

Congenital Heart Disease (CHD)

Investigational drug(s) / intervention(s)

Physical rehabilitation

Physical rehabilitation: Physical Rehabilitation in 36 sessions

Study summary

Studies have shown that patients with congenital heart disease have functional changes compared to healthy individuals. Several interventions can be performed to minimize these changes; physical rehabilitation is one of these possible treatments that can generate numerous benefits for patients. The aim of this study is to evaluate the response to physical rehabilitation in patients after surgical correction of congenital heart disease.

Methods This cross-sectional study included patients with complex congenital heart disease who underwent surgical correction. Different examinations were performed: cardiopulmonary exercise was used; and the six-minute walk test was used to determine functional capacity, the quality of life cardiac version questionnaire was used to determine quality of life. Descriptive analysis of patients was performed for all the data.

Eligibility

Sex
ALL
Min age
4 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * no previous or current history of other non-cardiological disease * patients undergoing complex congenital heart surgeries with a minimum postoperative period of 1 year * clinically stable; with no complex arrhythmia(s) in the last electrocardiogram or clinical evaluation * with medical monitoring * clinical clearance to carry out the protocols * consent with the Free and Informed Consent Form (FICF) and Assent Form signed by the guardian and the patient respectively. Exclusion Criteria: * patients with musculoskeletal or neuropsychiatric alterations without the possibility of performing a functional test (ergospirometry test), * hemodynamically unstable patients * severe respiratory or metabolic conditions * patients residing in regions far from São Paulo, * patients which make frequent visits to the institution unfeasible * patients who do not attend the rehabilitation program or those for whom it was not possible to maintain and update registration data.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital do Coração São Paulo São Paulo

More Hospital do Coracao trials in Brazil

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07089264 on ClinicalTrials.gov ↗ ← All trials in Brazil